Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome
To study plasma adiponectin levels in women diagnosed with polycystic ovary syndrome given omega-3 fatty acid supplements. A study was conducted in 195 women diagnosed with polycystic ovary syndrome treated with omega-3 fatty acids for 12weeks (n=97; groupA) and control women given placebo (n=98, gr...
Gespeichert in:
| Veröffentlicht in: | Endocrinologia, diabetes y nutricion diabetes y nutricion, 2018-04, Vol.65 (4), p.192-199 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 199 |
|---|---|
| container_issue | 4 |
| container_start_page | 192 |
| container_title | Endocrinologia, diabetes y nutricion |
| container_volume | 65 |
| creator | Mejia-Montilla, Jorly Reyna-Villasmil, Eduardo Domínguez-Brito, Lorena Naranjo-Rodríguez, Carmen Noriega-Verdugo, Delia Padilla-Samaniego, María Vargas-Olalla, Vanessa |
| description | To study plasma adiponectin levels in women diagnosed with polycystic ovary syndrome given omega-3 fatty acid supplements.
A study was conducted in 195 women diagnosed with polycystic ovary syndrome treated with omega-3 fatty acids for 12weeks (n=97; groupA) and control women given placebo (n=98, groupB). General characteristics, metabolism, lipid profile, and hormone and adiponectin levels were compared.
There were no significant differences between the two groups in general characteristics. No significant differences were also found in hormone, blood glucose, and HOMA levels between the groups. Women in study groupsA andB showed no statistically significant differences in total calorie, carbohydrate, protein, and total fat intake between the baseline and final values. Decreased total cholesterol, low-density lipoprotein, and triglyceride levels were found in groupA women (P |
| doi_str_mv | 10.1016/j.endinu.2017.12.010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2003051821</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2003051821</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-cf39a4cec81da0effee440f1d91a2511b3243b4525450c024d72f873672f6fee3</originalsourceid><addsrcrecordid>eNo1kEtrwzAQhEWhNCHNPyhFx17s7uoRJ8cS-oJAD23PRpHkVMGWVUtu8L-voCksDOx-MwxLyA1CiYCr-2NpvXF-LBlgVSIrAeGCzJnkUOQNm5FljEcAYFzIiuEVmbGNkKyS6zk5vI8htLazPqnkek9PLn3RvrMHVXDaqJQmqrQzkSpvaGhV7BRVxoXeW52cp3lOGT8bQ99OeorJadr_qGGicfJmyPdrctmoNtrlWRfk8-nxY_tS7N6eX7cPuyIwxFTohm-U0Fav0SiwTWOtENCg2aBiEnHPmeD7XF4KCRqYMBVr1hVfZVllmC_I3V9uGPrv0cZUdy5q27bK236MNQPgIHHNMKO3Z3Tcd9bUYXBdrlz_P4f_AvwxaNk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2003051821</pqid></control><display><type>article</type><title>Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Mejia-Montilla, Jorly ; Reyna-Villasmil, Eduardo ; Domínguez-Brito, Lorena ; Naranjo-Rodríguez, Carmen ; Noriega-Verdugo, Delia ; Padilla-Samaniego, María ; Vargas-Olalla, Vanessa</creator><creatorcontrib>Mejia-Montilla, Jorly ; Reyna-Villasmil, Eduardo ; Domínguez-Brito, Lorena ; Naranjo-Rodríguez, Carmen ; Noriega-Verdugo, Delia ; Padilla-Samaniego, María ; Vargas-Olalla, Vanessa</creatorcontrib><description>To study plasma adiponectin levels in women diagnosed with polycystic ovary syndrome given omega-3 fatty acid supplements.
A study was conducted in 195 women diagnosed with polycystic ovary syndrome treated with omega-3 fatty acids for 12weeks (n=97; groupA) and control women given placebo (n=98, groupB). General characteristics, metabolism, lipid profile, and hormone and adiponectin levels were compared.
There were no significant differences between the two groups in general characteristics. No significant differences were also found in hormone, blood glucose, and HOMA levels between the groups. Women in study groupsA andB showed no statistically significant differences in total calorie, carbohydrate, protein, and total fat intake between the baseline and final values. Decreased total cholesterol, low-density lipoprotein, and triglyceride levels were found in groupA women (P<.0001). Mean of adiponectin levels also showed a statistically significant increase after treatment (P<.0001). There were no statistically significant differences in the mean values of the different variables in groupB women.
Omega-3 fatty acid supplementation for 12weeks caused a significant increase in plasma adiponectin levels in women with polycystic ovary syndrome.</description><identifier>EISSN: 2530-0172</identifier><identifier>EISSN: 2530-0180</identifier><identifier>DOI: 10.1016/j.endinu.2017.12.010</identifier><identifier>PMID: 29452758</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Adiponectin - blood ; Dietary Supplements ; Fatty Acids, Omega-3 - therapeutic use ; Female ; Humans ; Polycystic Ovary Syndrome - blood ; Polycystic Ovary Syndrome - therapy ; Prospective Studies ; Young Adult</subject><ispartof>Endocrinologia, diabetes y nutricion, 2018-04, Vol.65 (4), p.192-199</ispartof><rights>Copyright © 2018 SEEN y SED. Publicado por Elsevier España, S.L.U. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29452758$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mejia-Montilla, Jorly</creatorcontrib><creatorcontrib>Reyna-Villasmil, Eduardo</creatorcontrib><creatorcontrib>Domínguez-Brito, Lorena</creatorcontrib><creatorcontrib>Naranjo-Rodríguez, Carmen</creatorcontrib><creatorcontrib>Noriega-Verdugo, Delia</creatorcontrib><creatorcontrib>Padilla-Samaniego, María</creatorcontrib><creatorcontrib>Vargas-Olalla, Vanessa</creatorcontrib><title>Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome</title><title>Endocrinologia, diabetes y nutricion</title><addtitle>Endocrinol Diabetes Nutr</addtitle><description>To study plasma adiponectin levels in women diagnosed with polycystic ovary syndrome given omega-3 fatty acid supplements.
A study was conducted in 195 women diagnosed with polycystic ovary syndrome treated with omega-3 fatty acids for 12weeks (n=97; groupA) and control women given placebo (n=98, groupB). General characteristics, metabolism, lipid profile, and hormone and adiponectin levels were compared.
There were no significant differences between the two groups in general characteristics. No significant differences were also found in hormone, blood glucose, and HOMA levels between the groups. Women in study groupsA andB showed no statistically significant differences in total calorie, carbohydrate, protein, and total fat intake between the baseline and final values. Decreased total cholesterol, low-density lipoprotein, and triglyceride levels were found in groupA women (P<.0001). Mean of adiponectin levels also showed a statistically significant increase after treatment (P<.0001). There were no statistically significant differences in the mean values of the different variables in groupB women.
Omega-3 fatty acid supplementation for 12weeks caused a significant increase in plasma adiponectin levels in women with polycystic ovary syndrome.</description><subject>Adiponectin - blood</subject><subject>Dietary Supplements</subject><subject>Fatty Acids, Omega-3 - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Polycystic Ovary Syndrome - blood</subject><subject>Polycystic Ovary Syndrome - therapy</subject><subject>Prospective Studies</subject><subject>Young Adult</subject><issn>2530-0172</issn><issn>2530-0180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtrwzAQhEWhNCHNPyhFx17s7uoRJ8cS-oJAD23PRpHkVMGWVUtu8L-voCksDOx-MwxLyA1CiYCr-2NpvXF-LBlgVSIrAeGCzJnkUOQNm5FljEcAYFzIiuEVmbGNkKyS6zk5vI8htLazPqnkek9PLn3RvrMHVXDaqJQmqrQzkSpvaGhV7BRVxoXeW52cp3lOGT8bQ99OeorJadr_qGGicfJmyPdrctmoNtrlWRfk8-nxY_tS7N6eX7cPuyIwxFTohm-U0Fav0SiwTWOtENCg2aBiEnHPmeD7XF4KCRqYMBVr1hVfZVllmC_I3V9uGPrv0cZUdy5q27bK236MNQPgIHHNMKO3Z3Tcd9bUYXBdrlz_P4f_AvwxaNk</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Mejia-Montilla, Jorly</creator><creator>Reyna-Villasmil, Eduardo</creator><creator>Domínguez-Brito, Lorena</creator><creator>Naranjo-Rodríguez, Carmen</creator><creator>Noriega-Verdugo, Delia</creator><creator>Padilla-Samaniego, María</creator><creator>Vargas-Olalla, Vanessa</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201804</creationdate><title>Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome</title><author>Mejia-Montilla, Jorly ; Reyna-Villasmil, Eduardo ; Domínguez-Brito, Lorena ; Naranjo-Rodríguez, Carmen ; Noriega-Verdugo, Delia ; Padilla-Samaniego, María ; Vargas-Olalla, Vanessa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-cf39a4cec81da0effee440f1d91a2511b3243b4525450c024d72f873672f6fee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2018</creationdate><topic>Adiponectin - blood</topic><topic>Dietary Supplements</topic><topic>Fatty Acids, Omega-3 - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Polycystic Ovary Syndrome - blood</topic><topic>Polycystic Ovary Syndrome - therapy</topic><topic>Prospective Studies</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mejia-Montilla, Jorly</creatorcontrib><creatorcontrib>Reyna-Villasmil, Eduardo</creatorcontrib><creatorcontrib>Domínguez-Brito, Lorena</creatorcontrib><creatorcontrib>Naranjo-Rodríguez, Carmen</creatorcontrib><creatorcontrib>Noriega-Verdugo, Delia</creatorcontrib><creatorcontrib>Padilla-Samaniego, María</creatorcontrib><creatorcontrib>Vargas-Olalla, Vanessa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrinologia, diabetes y nutricion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mejia-Montilla, Jorly</au><au>Reyna-Villasmil, Eduardo</au><au>Domínguez-Brito, Lorena</au><au>Naranjo-Rodríguez, Carmen</au><au>Noriega-Verdugo, Delia</au><au>Padilla-Samaniego, María</au><au>Vargas-Olalla, Vanessa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome</atitle><jtitle>Endocrinologia, diabetes y nutricion</jtitle><addtitle>Endocrinol Diabetes Nutr</addtitle><date>2018-04</date><risdate>2018</risdate><volume>65</volume><issue>4</issue><spage>192</spage><epage>199</epage><pages>192-199</pages><eissn>2530-0172</eissn><eissn>2530-0180</eissn><abstract>To study plasma adiponectin levels in women diagnosed with polycystic ovary syndrome given omega-3 fatty acid supplements.
A study was conducted in 195 women diagnosed with polycystic ovary syndrome treated with omega-3 fatty acids for 12weeks (n=97; groupA) and control women given placebo (n=98, groupB). General characteristics, metabolism, lipid profile, and hormone and adiponectin levels were compared.
There were no significant differences between the two groups in general characteristics. No significant differences were also found in hormone, blood glucose, and HOMA levels between the groups. Women in study groupsA andB showed no statistically significant differences in total calorie, carbohydrate, protein, and total fat intake between the baseline and final values. Decreased total cholesterol, low-density lipoprotein, and triglyceride levels were found in groupA women (P<.0001). Mean of adiponectin levels also showed a statistically significant increase after treatment (P<.0001). There were no statistically significant differences in the mean values of the different variables in groupB women.
Omega-3 fatty acid supplementation for 12weeks caused a significant increase in plasma adiponectin levels in women with polycystic ovary syndrome.</abstract><cop>Spain</cop><pmid>29452758</pmid><doi>10.1016/j.endinu.2017.12.010</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2530-0172 |
| ispartof | Endocrinologia, diabetes y nutricion, 2018-04, Vol.65 (4), p.192-199 |
| issn | 2530-0172 2530-0180 |
| language | eng ; spa |
| recordid | cdi_proquest_miscellaneous_2003051821 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adiponectin - blood Dietary Supplements Fatty Acids, Omega-3 - therapeutic use Female Humans Polycystic Ovary Syndrome - blood Polycystic Ovary Syndrome - therapy Prospective Studies Young Adult |
| title | Supplementation with omega-3 fatty acids and plasma adiponectin in women with polycystic ovary syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T20%3A59%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Supplementation%20with%20omega-3%20fatty%20acids%20and%20plasma%20adiponectin%20in%20women%20with%20polycystic%20ovary%20syndrome&rft.jtitle=Endocrinologia,%20diabetes%20y%20nutricion&rft.au=Mejia-Montilla,%20Jorly&rft.date=2018-04&rft.volume=65&rft.issue=4&rft.spage=192&rft.epage=199&rft.pages=192-199&rft.eissn=2530-0172&rft_id=info:doi/10.1016/j.endinu.2017.12.010&rft_dat=%3Cproquest_pubme%3E2003051821%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2003051821&rft_id=info:pmid/29452758&rfr_iscdi=true |